Grant: Catalyst Grant: Analysis of CLSA Data
McGill University
$68,000.00
Identifying metabolomic and proteomic biomarkers for cognitive function
FY 2022-23
Summary
Dementia is the most common chronic neurodegenerative disease which affects 7.1% of the Canadian populations over 65. The most common form of dementia is Alzheimer's disease (AD), which is diagnosed by severe cognitive decline. Retaining cognitive function is an important measure of healthy aging. To identify genetically supported multi-omic determinants (ie. proteins and metabolites) could help the discovery of new drugs of maintaining cognitive function, and reduce the risk of AD and the socioeconomic burden of our aging society. Here we propose a genetic epidemiological framework to identify robust proteomic and metabolomic determinants for cognitive function, using publicly available data and the Canadian Longitudinal Study on Aging (CLSA) cohort. We will utilize methods such as Mendelian randomization and statistical colocalization, combined with evidence from the direct association of metabolites with cognitive composite scores targeting memory and executive function and a protein polygenic risk score, to identify causal proteins and metabolites for AD and cognitive function. By leveraging the largest dataset with the most comprehensive metabolomic, genetic and cognitive function measurements, we expect to identify genetically supported biomarkers that could point to new therapeutic targets for early cognitive changes before the onset of dementia.
Department
Program
Catalyst Grant: Analysis of CLSA Data
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
468939
Name
Zhou Sirui
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Catalyst Grant: Analysis of CLSA Data
Projecttitle
Identifying metabolomic and proteomic biomarkers for cognitive function
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$68,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Analysis of CLSA Data
Keyworddelim
Alzheimer'S Disease; Cognitive Function; Metabolomics; Proteomics
Abstract
Dementia is the most common chronic neurodegenerative disease which affects 7.1% of the Canadian populations over 65. The most common form of dementia is Alzheimer's disease (AD), which is diagnosed by severe cognitive decline. Retaining cognitive function is an important measure of healthy aging. To identify genetically supported multi-omic determinants (ie. proteins and metabolites) could help the discovery of new drugs of maintaining cognitive function, and reduce the risk of AD and the socioeconomic burden of our aging society. Here we propose a genetic epidemiological framework to identify robust proteomic and metabolomic determinants for cognitive function, using publicly available data and the Canadian Longitudinal Study on Aging (CLSA) cohort. We will utilize methods such as Mendelian randomization and statistical colocalization, combined with evidence from the direct association of metabolites with cognitive composite scores targeting memory and executive function and a protein polygenic risk score, to identify causal proteins and metabolites for AD and cognitive function. By leveraging the largest dataset with the most comprehensive metabolomic, genetic and cognitive function measurements, we expect to identify genetically supported biomarkers that could point to new therapeutic targets for early cognitive changes before the onset of dementia.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhou, Sirui
Approvedterm
1 an 0 mois
Cihrcontribution2
Institute of Aging~ $68,000~ $0~